Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation

NCT03662477 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

NK Cell Mediated Immunity

Interventions

BIOLOGICAL: NK cells

Sponsor

Shenzhen Fifth People's Hospital